Evaluation of ocular biometry in the Japanese population using a multicenter approach: Prospective observational study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
01
2022
accepted:
07
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
This prospective observational study aimed to evaluate the ocular biometry of Japanese people through a multicenter approach. The uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively) in the log minimum angle of resolution (logMAR), subjective and objective spherical equivalent values (SE) of ocular refraction, anterior and posterior corneal curvature (ACC and PCC, respectively), anterior and posterior corneal asphericity (ACA and PCA, respectively), central corneal thickness (CCT), anterior chamber depth (ACD), and ocular axial length (AL) were measured in the eyes of 250 participants (mean age = 46.5 ± 18.0 years, range: 20-90 years) across five institutions in Japan. The mean UDVA, CDVA, subjective SE, objective SE, ACC, PCC, ACA, PCA, CCT, ACD, and AL were 0.68, -0.08, -2.42 D, -2.66 D, 7.77 mm, 6.33 mm, -0.31, -0.39, 0.55 mm, 2.92 mm, and 24.78 mm, respectively. Age-related changes and sex-based differences were noted in the visual acuity, refraction, corneal shape, ACD, and AL. Our results serve as basis for future studies aiming to develop refractive correction methods and various vision-related fields.
Identifiants
pubmed: 35895708
doi: 10.1371/journal.pone.0271814
pii: PONE-D-22-02113
pmc: PMC9328560
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271814Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5130-6
pubmed: 19553618
Ophthalmic Physiol Opt. 1986;6(1):39-46
pubmed: 3714274
Vision Res. 2006 Mar;46(6-7):993-1001
pubmed: 16266736
Vision Res. 2001 Jun;41(14):1867-77
pubmed: 11369049
Optom Vis Sci. 2013 Jun;90(6):587-98
pubmed: 23628758
Ophthalmology. 2008 Feb;115(2):363-370.e3
pubmed: 18243904
Invest Ophthalmol Vis Sci. 1997 Feb;38(2):321-33
pubmed: 9040464
Ophthalmology. 2021 Apr;128(4):522-531
pubmed: 32861683
Ophthalmic Physiol Opt. 2020 Nov;40(6):710-717
pubmed: 32860249
J Cataract Refract Surg. 2002 May;28(5):853-9
pubmed: 11978468
Clin Exp Optom. 2016 Mar;99(2):99-106
pubmed: 26969304
Optom Vis Sci. 1997 Jun;74(6):367-75
pubmed: 9255814
Acta Ophthalmol. 2010 Sep;88(6):e205-10
pubmed: 20670345
Invest Ophthalmol Vis Sci. 2011 Oct 10;52(11):7949-53
pubmed: 21896861
BMC Ophthalmol. 2016 Jun 07;16:79
pubmed: 27268271
J Med Genet. 2019 Oct;56(10):671-677
pubmed: 31189563
Lancet. 2012 May 5;379(9827):1739-48
pubmed: 22559900
J Opt Soc Am A Opt Image Sci Vis. 1997 Aug;14(8):1684-95
pubmed: 9248060
Optom Vis Sci. 1995 Dec;72(12):870-8
pubmed: 8749334
Optom Vis Sci. 2014 Jul;91(7):713-22
pubmed: 24927136
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):371-378
pubmed: 30506096
J Opt Soc Am A. 1985 Aug;2(8):1273-81
pubmed: 4032096